Several GLP-1 agonists are part of this program, including: Exenatide: Results from a large, phase 2 trial in 2017 suggested that exenatide may slow Parkinsons progression
The research team randomly administered either 8mg or 12mg of Retatrutide to the participants for eight months and tracked changes in their liver fat levels
Among those patients, 20% pursued plastic surgery post-weight loss, 39% were considering surgery, and 41% were considering nonsurgical options
NAC supplements lower oxidative stress markers and improve health measures like blood pressure and walking speed
Planning for Year-End: The FSA Deadline If you have a Flexible Spending Account (FSA) , the end of the year is a critical time
In these clinical trials, researchers study things like side effects and how well the drug works